Sherpa Venture Capital

Founded 2018

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 26
Average round size
info
The average size of a deal this fund participated in
$42M
Portfolio companies 26
Rounds per year 8.67
Lead investments 4
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.08
Exits 1
Key employees 2
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Pharmaceutical
  • Life Science
Summary

In 2018 was created Sherpa Venture Capital, which is appeared as VC. The venture was found in Asia in China. The leading representative office of defined VC is situated in the Beijing.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular fund investment industries, there are Medical Device, Clinical Trials. Among the most popular portfolio startups of the fund, we may highlight EpimAb Biotherapeutics, Singleron Biotechnologies, Immunochina. The fund has exact preference in a number of founders of portfolio startups.

The fund is constantly included in 7-12 investment rounds annually. Considering the real fund results, this VC is 60 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2019.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Sherpa Venture Capital, startups are often financed by Trend Investment Group, Thiel Capital, ShengJing360. The meaningful sponsors for the fund in investment in the same round are Legend Capital, Hillhouse Capital Group, WuXi AppTec.

We also calculated 2 valuable employees in our database.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Sherpa Venture Capital:
Typical Co-investors
Sherpa Venture Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Sherpa Venture Capital:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from China, Beijing
Funds with similar focus located in China, Beijing:
Funds with the same geo focus
Funds with similar geography of portfolio companies:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
3taps United States, San Francisco
Edison Electric Institute United States, Washington
Escala Partners Australia, Melbourne
Shining Capital China, Hong Kong Island
DOTCOM Ventures -
Sichuan Hongbo Equity Investment Fund Management China, Gansu
Great Wall Motors China, Hebei
Huaxin Lianzhong Touzi China, Beijing
Sparks Capital -
DOTCOM Ventures -
Founders & Fools Norway, Oslo

Notable deals

CompanyIndustryRoundRound SizeDateInvestorsLocation

CashBackApp

Mobile Apps
1
$475K19 Aug 2021 Kenya, Nairobi

Neukio Biotherapeutics

Biotechnology
1
$40M29 Jul 2021 China, Shanghai

PAQ Therapeutics

Biotechnology
Health Care
Therapeutics
1
$30M15 Jul 2021 United States, Cambridge

HiFiBiO

Biopharma
Biotechnology
Pharmaceutical
Therapeutics
1
$75M14 Jun 2021 France, Paris

XISOFT

Health Care
Hospital
Information Technology
Management Consulting
1
$15M27 May 2021 China, Shanghai

Biotechnology
Life Science
1
$52M11 May 2021 United States, Los Angeles

Biotechnology
Life Science
Pharmaceutical
1
$60M09 May 2021 China, Shanghai

EdiGene

Biotechnology
Genetics
Health Care
1
$61M21 Apr 2021 China, Dongcheng District

Health Care
Health Diagnostics
Medical
Medical Device
1
$20M06 Apr 2021 China, Shanghai

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Sherpa Venture Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: